Browsing archives for September, 2018

NORML Endorses Utah’s Proposition 2

Generic 20 September 2018 | 0 Comments

The National Organization for the Reform of Marijuana Laws (NORML) endorses Proposition 2: The Utah Medical Cannabis Act, which regulates the licensed production and distribution of medical cannabis products to qualified patients who possess a physician’s recommendation. Seventy-seven percent of adults express support for the law change, according to statewide polling data compiled in March. [...]

Cannabinoid drugs make pain feel ‘less unpleasant, more tolerable’

Did you know that? 19 September 2018 | 0 Comments

Researchers have determined that cannabinoid drugs do not appear to reduce the intensity of experimental pain, but, instead, may make pain feel less unpleasant and more tolerable.

The effectiveness of online cannabis responsible vendor training program

Did you know that? 17 September 2018 | 0 Comments

A new study on the quality of online responsible marijuana vendor for cannabis (RMV) training has just been released. The study used an online RMV training that was developed in consultation with state regulators, store personnel, and local law enforcement in Colorado and Washington state. The training focused on knowledge of state statutes and regulations, [...]

Tagged in ,

NORML Responds to US Border Policy Barring Canadians Involved In Legal Marijuana Market

Generic 15 September 2018 | 0 Comments

NORML staff today responded to reports that the US Customs and Border Protection Agency will enforce a federal policy denying entry into the United States any individual involved Canada’s burgeoning marijuana market. Under the policy, US officials are to bar entry to Canadians who acknowledge having consumed marijuana at any time in their past, as [...]

Tagged in , ,

Weekly Legislative Roundup 9/14/18

Generic 15 September 2018 | 0 Comments

Welcome to the latest edition of NORML’s Weekly Legislative Roundup! The U.S. House Judiciary Committee approved legislation (HR 5634: The Medical Cannabis Research Act of 2018) to facilitate federally-approved clinical trials assessing the efficacy of whole-plant cannabis. The vote marks the first time that lawmakers have ever decided in favor of easing existing federal restrictions [...]

Tagged in , , ,